Antibiotic Treatment for Prostatitis

Acute Bacterial Prostatitis

The American Urological Association recommends ciprofloxacin 500-750 mg orally twice daily for 2-4 weeks as the first-line choice when local fluoroquinolone resistance is below 10% 1, 2
For severe cases requiring hospitalization, ceftriaxone or cefotaxime are first-choice IV options 2, 3
Ciprofloxacin 400 mg IV twice daily can be used as parenteral therapy, with transition to oral antibiotics once clinically improved 1
Amikacin is a second-choice option for severe prostatitis 2
Hospitalization with IV antibiotics is indicated for patients unable to tolerate oral medications, those with risk of urosepsis, or those with fever and systemic toxicity, which occurs in 7.3% of cases 1

The European Urology guidelines suggest testing for atypical pathogens including Chlamydia trachomatis and Mycoplasma species, which require specific antimicrobial therapy 4, 1
The Meares-Stamey 4-glass test or a simplified 2-specimen variant can be used to diagnose chronic bacterial prostatitis, with a positive result showing 10-fold higher bacterial count in expressed prostatic secretions than midstream urine 1

The Centers for Disease Control and Prevention recommends azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days for the treatment of Chlamydia trachomatis and Mycoplasma 5

The European Urology guidelines advise against performing prostatic massage in acute bacterial prostatitis due to the risk of bacteremia 4, 1
Local resistance patterns should guide antibiotic selection, with fluoroquinolone resistance ideally less than 10% for empiric use 1

The European Urology guideline recommends levofloxacin 750 mg orally once daily as an alternative fluoroquinolone option for acute bacterial prostatitis, with consideration of local resistance patterns 6
The European Urology guideline suggests ceftriaxone 1-2 g IV once daily or cefotaxime 2 g IV three times daily as first-choice parenteral options for severe cases of acute bacterial prostatitis 6
The European Urology guideline recommends piperacillin-tazobactam 2.5-4.5 g IV three times daily for broad-spectrum coverage in acute bacterial prostatitis 6
The European Urology guideline suggests considering carbapenems or novel broad-spectrum agents for healthcare-associated infections with enterococci or multidrug-resistant organisms in acute bacterial prostatitis 6

The Centers for Disease Control and Prevention recommends a combination regimen of ceftriaxone 250-1000 mg IM/IV once daily plus doxycycline 100 mg orally twice daily for the treatment of acute prostatitis in younger men with risk factors for sexually transmitted infections 7
For men who have sex with men presenting with acute proctitis and prostatitis, the Centers for Disease Control and Prevention recommends ceftriaxone 250 mg IM single dose plus doxycycline 100 mg orally twice daily for 7 days 7
If lymphogranuloma venereum (LGV) is suspected, the Centers for Disease Control and Prevention recommends extending doxycycline to 100 mg twice daily for 3 weeks 7

The Centers for Disease Control and Prevention recommends doxycycline 100 mg orally twice daily for 7 days for the treatment of ureaplasmal prostatitis, which accounts for 20-40% of nongonococcal urethritis cases, with similar microbiological and clinical efficacy compared to other agents 8
Doxycycline remains an effective alternative for the treatment of chlamydial prostatitis, although macrolides (azithromycin) have demonstrated higher cure rates than fluoroquinolones 8

Tetracycline-resistant Ureaplasma urealyticum can cause treatment failure after doxycycline, and switching to erythromycin base 500 mg four times daily for 14 days may be necessary, as recommended by the MMWR Recommendations and Reports 8

The treatment duration for chronic prostatitis may be 2-3 months for complete eradication, and doxycycline 100 mg twice daily for 7 days may be used for atypical pathogens, including Chlamydia trachomatis and Mycoplasma species 8